Article info
PDFPostScript
Letter
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis
- Correspondence to Dr P Foley, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK; peterfoley{at}nhs.net
Citation
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis
Publication history
- Received September 20, 2013
- Revised November 29, 2013
- Accepted December 11, 2013
- First published January 8, 2014.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions